ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 964,17
0,63%
Dow Jones
38 225,66
0,85%
DAX
17 981,83
0,43%
Brent Oil
83,845
0,26%
Bitcoin
59 022,58
-0,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allarity Therapeutics Inc (ALLR)

  7. Allarity Therapeutics Inc (ALLR) Actualités

ALLR Allarity Therapeutics Inc

1,21
-0,02 (-1,63%)
Avant marché
Dernière mise à jour : 13:02:10
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Allarity Therapeutics Inc ALLR NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,02 -1,63% 1,21 13:02:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,23
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202414:00GLOBEAllarity Therapeutics’ Stenoparib Shows Clear Clinical..
29/4/202413:00GLOBEAllarity Therapeutics Regains Compliance with NASDAQ Minimum..
17/4/202415:10GLOBEAllarity Therapeutics Receives NASDAQ-Approved Extension to..
04/4/202415:15GLOBEAllarity Therapeutics Announces 1-for-20 Reverse Stock Split
27/3/202413:30GLOBEAllarity Therapeutics Makes Strategic Pivot to Focus Solely..
25/3/202412:30GLOBEAllarity Therapeutics Receives Extension from Nasdaq..
08/3/202414:38EDGAR2Form 8-K - Current report
08/3/202413:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/3/202413:15GLOBEAllarity Therapeutics Reports Full Year 2023 Financial..
08/3/202403:45EDGAR2Form DEF 14A - Other definitive proxy statements
04/3/202422:05EDGAR2Form 8-K - Current report
01/3/202415:21EDGAR2Form 8-K - Current report
28/2/202412:00GLOBEAllarity Therapeutics to Present at Biomarkers 2024
23/2/202422:09EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
14/2/202415:03EDGAR2Form 8-K - Current report
02/2/202423:03EDGAR2Form D - Notice of Exempt Offering of Securities
01/2/202422:40EDGAR2Form 8-K - Current report
26/1/202423:07EDGAR2Form PRE 14A - Other preliminary proxy statements
25/1/202423:24EDGAR2Form 8-K - Current report
19/1/202423:29EDGAR2Form 8-K - Current report
15/12/202323:00EDGAR2Form S-1/A - General form for registration of securities..
12/12/202312:00GLOBEAllarity Therapeutics Announces Thomas Jensen as Interim CEO..
11/12/202312:30EDGAR2Form 8-K - Current report
06/12/202323:00EDGAR2Form 8-K - Current report
06/12/202314:30EDGAR2Form S-1/A - General form for registration of securities..
05/12/202313:30EDGAR2Form 8-K - Current report
05/12/202313:30GLOBEAllarity’s Early Phase 2 Stenoparib Data Indicates Clinical..
17/11/202323:01EDGAR2Form 8-K - Current report
13/11/202314:35EDGAR2Form 8-K - Current report
02/11/202322:00EDGAR2Form S-3 - Registration statement under Securities Act of..
31/10/202314:30EDGAR2Form S-1 - General form for registration of securities under..
30/10/202322:00EDGAR2Form 8-K - Current report
23/10/202323:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/10/202323:00EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/10/202323:00EDGAR2Form S-3 - Registration statement under Securities Act of..
02/10/202313:00GLOBEAllarity Therapeutics to Present at Biomarkers Europe 2023
27/9/202322:30EDGAR2Form 8-K - Current report
15/9/202314:45EDGAR2Form 8-K - Current report
30/8/202322:05GLOBEPLOS ONE Publishes Data on Allarity Therapeutics’ DRP®..
14/8/202321:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202314:15EDGAR2Form 8-K - Current report
31/7/202312:00GLOBEAllarity Therapeutics and FivepHusion Announce Collaboration..
27/7/202322:01EDGAR2Form 8-K - Current report
24/7/202312:00GLOBEAllarity Therapeutics Strengthens Board of Directors with..
17/7/202323:10EDGAR2Form 8-K - Current report
11/7/202322:05EDGAR2Form 8-K - Current report
07/7/202322:30EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/7/202312:05EDGAR2Form 8-K - Current report
06/7/202312:00GLOBEAllarity Therapeutics, Inc. Announces Pricing of $11 Million..
05/7/202322:31EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
ALLR
Allarity Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés